18F-FMISO
Showing 1 - 25 of >10,000
Hypoxia Before Radioembolization Treatment With 18F-FMISO PET
Recruiting
- Radioembolization
- +3 more
- 18F-Fluoromisonidazole PET
-
Ankara, TurkeyAnkara University
Sep 7, 2023
Idiopathic Pulmonary Fibrosis Trial in Dijon (FMISO-PET Protocol)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- FMISO-PET Protocol
-
Dijon, FranceChu Dijon Bourgogne
Jul 5, 2022
Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),
Recruiting
- Brain Cancer
- [18F]fluoro-2-deoxy-D-glucose (FDG)
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 3, 2023
HER2-positive Breast Cancer Trial in Birmingham ([18F]FMISO PET/MRI imaging)
Recruiting
- HER2-positive Breast Cancer
- [18F]FMISO PET/MRI imaging
-
Birmingham, AlabamaThe University of Alabama at Birmingham
Dec 8, 2022
Non-Small-Cell-Lung Cancer (NSCLC) Trial in New York (18F-FMISO, PET/CT)
Active, not recruiting
- Non-Small-Cell-Lung Cancer (NSCLC)
- 18F-FMISO
- PET/CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2022
Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)
Not yet recruiting
- Triple Negative Breast Cancer
- [18F]FMISO-PET with contrast-enhanced MRI
-
Birmingham, AlabamaUAB
Nov 15, 2022
Head Neck Cancer Trial in United States (fluorine-18-labeled fluoro-misonidazole (18F-FMISO), 18F-FMISO PET scan, MRI)
Active, not recruiting
- Head and Neck Cancer
- fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jul 8, 2022
Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- DE-HyART
- +3 more
-
Delhi, IndiaRajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023
Nasopharyngeal Carcinoma Trial in Singapore ((18)F-fluoromisonidazole (FMISO))
Completed
- Nasopharyngeal Carcinoma
- (18)F-fluoromisonidazole (FMISO)
-
Singapore, Singapore
- +1 more
Aug 9, 2021
Malignant Brain Tumor Trial in Portland (¹8F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging)
Recruiting
- Malignant Brain Neoplasm
- ¹⁸F-Fluoromisonidazole
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 19, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Little Rock (18F-MISO)
Withdrawn
- Squamous Cell Carcinoma of the Head and Neck
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Aug 17, 2021
Soft Tissue Sarcoma Trial in Philadelphia (18F-FMISO)
Terminated
- Soft Tissue Sarcoma
- 18F-FMISO
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 15, 2021
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Hepatocellular Carcinoma Trial in Birmingham (FMISO)
Terminated
- Hepatocellular Carcinoma
-
Birmingham, AlabamaUAB Advanced Imaging Facility
Feb 15, 2021
HPV, Throat Cancer, Oropharyngeal Carcinoma Trial in United States (diagnostic test, radiation, drug)
Recruiting
- HPV
- +4 more
- 18 F-FMISO PET/CT
- +4 more
-
Basking Ridge, New Jersey
- +6 more
Aug 4, 2022
Head Neck Cancer, Head and Neck Carcinoma, Head and Neck Tumors Trial in United States (diagnostic test, radiation, drug)
Recruiting
- Head and Neck Cancer
- +3 more
- 18F-FMISO PET/CT scan
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Sep 15, 2022
Recurrent Glioblastoma Trial in Philadelphia (biological, drug, radiation)
Terminated
- Recurrent Glioblastoma
- [18F]fluoromisonidazole
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 13, 2020
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's
Recruiting
- Alzheimer's Disease
- [18F]Florbetazine ([18F]92)
- [11C]PIB
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023
Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and
Recruiting
- Breast Cancer
- +4 more
- 18F-FDG PET/CT
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 17, 2023
Novel Hypoxia Imaging for Head and Neck Cancer: Imaging
Not yet recruiting
- Head and Neck Cancer
- +3 more
- [18F]MISO-PET/CT
- (no location specified)
Oct 29, 2023
Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)
Not yet recruiting
- Breast Cancer
- Brain Metastases
- Brain Imaging with 18F-FES
-
New York, New YorkNew York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023
Study of 18F-FAPI Applied to Gastrointestinal Cancer
Not yet recruiting
- Gastrointestinal Cancer
- 18F-FAPI and 18F-FDG PET/CT
- (no location specified)
Mar 28, 2023
Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)
Recruiting
- Tumor, Solid
- Radiation: 18F-AlF-FAPi-04
- Radiation: 18F-FDG
-
Nanchong, Sichuan, ChinaAffiliated Hospital of North Sichuan Medical College
Nov 6, 2023